{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:33:11Z","timestamp":1760783591674},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,14]],"date-time":"2012-09-14T00:00:00Z","timestamp":1347580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00540-012-1482-7","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T08:19:10Z","timestamp":1347524350000},"page":"128-131","source":"Crossref","is-referenced-by-count":2,"title":["A family with discordance between malignant hyperthermia susceptibility and rippling muscle disease"],"prefix":"10.1007","volume":"27","author":[{"given":"Jimmy","family":"Sundblom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atle","family":"Melberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"R\u00fccker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla","family":"Islander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,14]]},"reference":[{"key":"1482_CR1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2008.05.003","volume":"18","author":"A Aboumousa","year":"2008","unstructured":"Aboumousa A, Hoogendijk J, Charlton R, Barresi R, Herrmann R, Voit T, Hudson J, Roberts M, Hilton-Jones D, Eagle M, Bushby K, Straub V. Caveolinopathy\u2014new mutations and additional symptoms. Neuromuscul Disord. 2008;18:572\u20138.","journal-title":"Neuromuscul Disord"},{"key":"1482_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ejhg.2009.103","volume":"18","author":"E Gazzerro","year":"2010","unstructured":"Gazzerro E, Sotgia F, Bruno C, Lisanti M, Minetti C. Caveolinopathies: from the biology of caveolin-3 to human diseases. Eur J Hum Genet. 2010;18:137\u201345.","journal-title":"Eur J Hum Genet"},{"key":"1482_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0404.1975.tb07603.x","volume":"51","author":"T Torbergsen","year":"1975","unstructured":"Torbergsen T. A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita Thomsen. Acta Neurol Scand. 1975;51:225\u201332.","journal-title":"Acta Neurol Scand"},{"key":"1482_CR4","doi-asserted-by":"crossref","unstructured":"Torbergsen T. Rippling muscle disease: a review. Muscle Nerve. 2002;Suppl 11:S103\u20137.","DOI":"10.1002\/mus.10156"},{"key":"1482_CR5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archneur.1989.00520400065020","volume":"46","author":"K Ricker","year":"1989","unstructured":"Ricker K, Moxley RT, Rohkamm R. Rippling muscle disease. Arch Neurol. 1989;46:405\u20138.","journal-title":"Arch Neurol"},{"key":"1482_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mus.21947","volume":"43","author":"T Maki","year":"2011","unstructured":"Maki T, Matsumoto R, Kohara N, Kondo T, Son I, Mezaki T, Nishino I, Ikeda A, Takahashi R. Rippling is not always electrically silent in rippling muscle disease. Muscle Nerve. 2011;43:601\u20135.","journal-title":"Muscle Nerve"},{"key":"1482_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007;2:21.","journal-title":"Orphanet J Rare Dis"},{"key":"1482_CR8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-2346.2001.00888.x","volume":"18","author":"F Wappler","year":"2001","unstructured":"Wappler F. Malignant hyperthermia. Eur J Anaesthesiol. 2001;18:632\u201352.","journal-title":"Eur J Anaesthesiol"},{"key":"1482_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","volume":"23","author":"K Jurkat-Rott","year":"2000","unstructured":"Jurkat-Rott K, McCarthy T, Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve. 2000;23:4\u201317.","journal-title":"Muscle Nerve"},{"key":"1482_CR10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","volume":"60","author":"N Monnier","year":"1997","unstructured":"Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet. 1997;60:1316\u201325.","journal-title":"Am J Hum Genet"},{"key":"1482_CR11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"A Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth. 2001;86:283\u20137.","journal-title":"Br J Anaesth"},{"key":"1482_CR12","volume-title":"Gene reviews (internet)","author":"C Bruno","year":"2007","unstructured":"Bruno C, Sotgia F, Gazzerro E, Minetti C, Lisanti MP. Caveolinopathies. In: Pagon R, Bird TD, Dolan CR, Stephens K, Adams MP, editors. Gene reviews (internet). Seattle: University of Washington; 2007."},{"key":"1482_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mus.21589","volume":"41","author":"J Sundblom","year":"2010","unstructured":"Sundblom J, St\u00e5lberg E, \u00d6sterdahl M, R\u00fccker F, Montelius M, Kalimo H, Nennesmo I, Islander G, Smits A, Dahl N, Melberg A. Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers. Muscle Nerve. 2010;41:751\u20137.","journal-title":"Muscle Nerve"},{"key":"1482_CR14","unstructured":"Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurdsson S, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wappler F. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand. 1997;41:955\u201366."},{"key":"1482_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2044-5040-1-26","volume":"1","author":"L Al-Qusairi","year":"2011","unstructured":"Al-Qusairi L, Laporte J. T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle. 2011;1:26.","journal-title":"Skelet Muscle"},{"key":"1482_CR16","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/bi100796v","volume":"49","author":"S Vassilopoulos","year":"2010","unstructured":"Vassilopoulos S, Oddoux S, Groh S, Cacheux M, Faur\u00e9 J, Brocard J, Campbell KP, Marty I. Caveolin 3 is associated with the calcium release complex and is modified via in vivo triadin modification. Biochemistry. 2010;49:6130\u20135.","journal-title":"Biochemistry"},{"key":"1482_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00424-008-0528-z","volume":"457","author":"N Weiss","year":"2008","unstructured":"Weiss N, Couchoux H, Legrand C, Berthier C, Allard B, Jacquemond V. Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca(2+) channel function of the dihydropyridine receptor. Pfl\u00fcgers Archiv. 2008;457:361\u201375.","journal-title":"Pfl\u00fcgers Archiv"},{"key":"1482_CR18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1113\/jphysiol.2006.124198","volume":"580","author":"H Couchoux","year":"2007","unstructured":"Couchoux H, Allard B, Legrand C, Jacquemond V, Berthier C. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells. J Physiol. 2007;580:745\u201354.","journal-title":"J Physiol"},{"key":"1482_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1085\/jgp.200810105","volume":"133","author":"RA Bannister","year":"2009","unstructured":"Bannister RA, Pessah IN, Beam KG. The skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry. J Gen Physiol. 2009;133:79\u201391.","journal-title":"J Gen Physiol"},{"issue":"3","key":"1482_CR20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/humu.21431","volume":"32","author":"ND Ullrich","year":"2011","unstructured":"Ullrich ND, Fischer D, Kornblum C, Walter MC, Niggli E, Zorzato F, Treves S. Alterations of excitation\u2013contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle. Hum Mutat. 2011;32(3):309\u201317.","journal-title":"Hum Mutat"},{"key":"1482_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1006\/bbrc.1999.1534","volume":"264","author":"GR Walker","year":"1999","unstructured":"Walker GR, Watkins T, Ansevin CF. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels. Biochem Biophys Res Commun. 1999;264:430\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1482_CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene\u2014a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59:364\u201373.","journal-title":"Anaesthesia"},{"key":"1482_CR23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/ane.0b013e3181a7c8e5","volume":"109","author":"J Parness","year":"2009","unstructured":"Parness J, Bandschapp O, Girard T. The myotonias and susceptibility to malignant hyperthermia. Anesth Analg. 2009;109:1054\u201364.","journal-title":"Anesth Analg"},{"key":"1482_CR24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1213\/ane.0b013e3181b493d4","volume":"109","author":"PJ Davis","year":"2009","unstructured":"Davis PJ, Brandom BW. The association of malignant hyperthermia and unusual disease: when you\u2019re hot you\u2019re hot or maybe not. Anesth Analg. 2009;109:1001\u20133.","journal-title":"Anesth Analg"},{"key":"1482_CR25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1213\/ane.0b013e3181adca28","volume":"109","author":"J Benca","year":"2009","unstructured":"Benca J, Hogan K. Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options. Anesth Analg. 2009;109:1049\u201353.","journal-title":"Anesth Analg"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-012-1482-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-012-1482-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-012-1482-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:47:41Z","timestamp":1559098061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-012-1482-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1007\/s00540-012-1482-7","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,14]]}}}